Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R van Altena

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Antimicrobial Agents and Chemotherapy|January 11, 2017
Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant TuberculosisR van Altena, J A Dijkstra, M E van der Meer, et al.
Antimicrobial Agents and Chemotherapy|August 29, 2012
Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosisD H Vu, M S Bolhuis, R A Koster, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 11, 2015
Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009R van Altena, G de Vries, C H Haar, et al.
Antimicrobial Agents and Chemotherapy|May 22, 2013
Clinical validation of the analysis of linezolid and clarithromycin in oral fluid of patients with multidrug-resistant tuberculosisM S Bolhuis, R van Altena, K van Hateren, et al.
International Journal of Antimicrobial Agents|July 3, 2014
Population pharmacokinetics and limited sampling strategy for first-line tuberculosis drugs and moxifloxacinC Magis-Escurra, H M J Later-Nijland, J W C Alffenaar, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2018
Pharmacokinetics of 2,000 Milligram Ertapenem in Tuberculosis PatientsM A Zuur, S Ghimire, M S Bolhuis, et al.
Antimicrobial Agents and Chemotherapy|February 1, 2017
Pharmacokinetic Modeling and Limited Sampling Strategies Based on Healthy Volunteers for Monitoring of Ertapenem in Patients with Multidrug-Resistant TuberculosisS P van Rijn, M A Zuur, R van Altena, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 2, 2022
Clinical standards for the dosing and management of TB drugsJ W C Alffenaar, S L Stocker, L Davies Forsman, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 24, 2023
Clinical standards for the management of adverse effects during treatment for TBK P Singh, A C C Carvalho, R Centis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 14, 2016
Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data MetaanalysisGregory J Fox, Carole D Mitnick, Andrea Benedetti, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Antimicrobial Agents and Chemotherapy|January 11, 2017
Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant TuberculosisR van Altena, J A Dijkstra, M E van der Meer, et al.
Antimicrobial Agents and Chemotherapy|August 29, 2012
Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosisD H Vu, M S Bolhuis, R A Koster, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 11, 2015
Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009R van Altena, G de Vries, C H Haar, et al.
Antimicrobial Agents and Chemotherapy|May 22, 2013
Clinical validation of the analysis of linezolid and clarithromycin in oral fluid of patients with multidrug-resistant tuberculosisM S Bolhuis, R van Altena, K van Hateren, et al.
International Journal of Antimicrobial Agents|July 3, 2014
Population pharmacokinetics and limited sampling strategy for first-line tuberculosis drugs and moxifloxacinC Magis-Escurra, H M J Later-Nijland, J W C Alffenaar, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2018
Pharmacokinetics of 2,000 Milligram Ertapenem in Tuberculosis PatientsM A Zuur, S Ghimire, M S Bolhuis, et al.
Antimicrobial Agents and Chemotherapy|February 1, 2017
Pharmacokinetic Modeling and Limited Sampling Strategies Based on Healthy Volunteers for Monitoring of Ertapenem in Patients with Multidrug-Resistant TuberculosisS P van Rijn, M A Zuur, R van Altena, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 2, 2022
Clinical standards for the dosing and management of TB drugsJ W C Alffenaar, S L Stocker, L Davies Forsman, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 24, 2023
Clinical standards for the management of adverse effects during treatment for TBK P Singh, A C C Carvalho, R Centis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 14, 2016
Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data MetaanalysisGregory J Fox, Carole D Mitnick, Andrea Benedetti, et al.
Pageof 6